vs
Assertio Holdings, Inc.（ASRT）与SWK Holdings Corp（SWKH）财务数据对比。点击上方公司名可切换其他公司
Assertio Holdings, Inc.的季度营收约是SWK Holdings Corp的1.6倍（$13.5M vs $8.7M），SWK Holdings Corp同比增速更快（-29.7% vs -57.9%），过去两年SWK Holdings Corp的营收复合增速更高（-12.5% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
SWK Holdings Corp是一家专注于医疗健康与生命科学领域的专业金融企业，为生物技术、制药、医疗器械及诊断类企业提供特许权使用费货币化、结构性债务、资产支持贷款等定制化融资服务，核心市场以北美地区为主。
ASRT vs SWKH — 直观对比
营收规模更大
ASRT
是对方的1.6倍
$8.7M
营收增速更快
SWKH
高出28.2%
-57.9%
两年增速更快
SWKH
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $8.7M |
| 净利润 | — | $-19.4M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | 9.9% |
| 净利率 | — | — |
| 营收同比 | -57.9% | -29.7% |
| 净利润同比 | — | -430.2% |
| 每股收益（稀释后） | $-4.54 | $-1.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTSWKH
| Q4 25 | $13.5M | $8.7M | ||
| Q3 25 | $49.5M | $10.9M | ||
| Q2 25 | $29.2M | $10.1M | ||
| Q1 25 | $26.5M | $11.8M | ||
| Q4 24 | $32.2M | $12.4M | ||
| Q3 24 | $29.2M | $10.4M | ||
| Q2 24 | $31.1M | $10.8M | ||
| Q1 24 | $32.4M | $11.4M |
净利润ASRTSWKH
| Q4 25 | — | $-19.4M | ||
| Q3 25 | $11.4M | $8.8M | ||
| Q2 25 | $-16.4M | $3.5M | ||
| Q1 25 | $-13.5M | $4.5M | ||
| Q4 24 | — | $5.9M | ||
| Q3 24 | $-2.9M | $3.5M | ||
| Q2 24 | $-3.7M | $3.7M | ||
| Q1 24 | $-4.5M | $468.0K |
营业利润率ASRTSWKH
| Q4 25 | -86.7% | 9.9% | ||
| Q3 25 | 23.2% | 61.3% | ||
| Q2 25 | -27.5% | 46.1% | ||
| Q1 25 | -50.0% | 68.6% | ||
| Q4 24 | -41.9% | 44.7% | ||
| Q3 24 | -10.4% | 39.2% | ||
| Q2 24 | -11.6% | 8.3% | ||
| Q1 24 | -13.4% | 9.5% |
净利率ASRTSWKH
| Q4 25 | — | — | ||
| Q3 25 | 23.1% | 80.7% | ||
| Q2 25 | -56.0% | 35.2% | ||
| Q1 25 | -51.1% | 38.4% | ||
| Q4 24 | — | 47.5% | ||
| Q3 24 | -10.0% | 33.3% | ||
| Q2 24 | -11.8% | 33.9% | ||
| Q1 24 | -13.9% | 4.1% |
每股收益（稀释后）ASRTSWKH
| Q4 25 | $-4.54 | $-1.59 | ||
| Q3 25 | $0.11 | $0.72 | ||
| Q2 25 | $-0.17 | $0.29 | ||
| Q1 25 | $-0.14 | $0.37 | ||
| Q4 24 | $-3.28 | $0.47 | ||
| Q3 24 | $-0.03 | $0.28 | ||
| Q2 24 | $-0.04 | $0.30 | ||
| Q1 24 | $-0.05 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $42.8M |
| 总债务越低越好 | — | $33.0M |
| 股东权益账面价值 | $94.0M | $235.1M |
| 总资产 | $267.0M | $272.4M |
| 负债/权益比越低杠杆越低 | — | 0.14× |
8季度趋势，按日历期对齐
现金及短期投资ASRTSWKH
| Q4 25 | $63.4M | $42.8M | ||
| Q3 25 | $93.4M | $10.2M | ||
| Q2 25 | $98.2M | $8.0M | ||
| Q1 25 | $87.3M | $29.8M | ||
| Q4 24 | $100.1M | $5.9M | ||
| Q3 24 | $88.6M | $17.2M | ||
| Q2 24 | $88.4M | $5.5M | ||
| Q1 24 | $80.7M | $5.5M |
总债务ASRTSWKH
| Q4 25 | — | $33.0M | ||
| Q3 25 | — | $33.0M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $33.0M | ||
| Q4 24 | — | $33.0M | ||
| Q3 24 | — | $33.0M | ||
| Q2 24 | — | $33.0M | ||
| Q1 24 | $38.6M | $33.0M |
股东权益ASRTSWKH
| Q4 25 | $94.0M | $235.1M | ||
| Q3 25 | $105.8M | $254.2M | ||
| Q2 25 | $93.3M | $246.5M | ||
| Q1 25 | $108.5M | $292.7M | ||
| Q4 24 | $121.1M | $288.7M | ||
| Q3 24 | $130.5M | $283.4M | ||
| Q2 24 | $132.2M | $282.8M | ||
| Q1 24 | $134.5M | $279.9M |
总资产ASRTSWKH
| Q4 25 | $267.0M | $272.4M | ||
| Q3 25 | $319.8M | $289.4M | ||
| Q2 25 | $273.8M | $285.7M | ||
| Q1 25 | $286.4M | $331.3M | ||
| Q4 24 | $284.7M | $332.2M | ||
| Q3 24 | $276.0M | $321.3M | ||
| Q2 24 | $279.4M | $321.0M | ||
| Q1 24 | $282.0M | $322.0M |
负债/权益比ASRTSWKH
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | 0.29× | 0.12× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $27.3M |
| 自由现金流经营现金流 - 资本支出 | — | $26.8M |
| 自由现金流率自由现金流/营收 | — | 308.1% |
| 资本支出强度资本支出/营收 | — | 5.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $43.2M |
8季度趋势，按日历期对齐
经营现金流ASRTSWKH
| Q4 25 | $-30.0M | $27.3M | ||
| Q3 25 | $-4.8M | $906.0K | ||
| Q2 25 | $19.1M | $7.8M | ||
| Q1 25 | $-12.5M | $8.3M | ||
| Q4 24 | $11.5M | $23.0M | ||
| Q3 24 | $-35.0K | $6.3M | ||
| Q2 24 | $7.4M | $5.4M | ||
| Q1 24 | $7.5M | $4.4M |
自由现金流ASRTSWKH
| Q4 25 | — | $26.8M | ||
| Q3 25 | — | $557.0K | ||
| Q2 25 | — | $7.7M | ||
| Q1 25 | — | $8.2M | ||
| Q4 24 | — | $22.9M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $5.4M | ||
| Q1 24 | — | — |
自由现金流率ASRTSWKH
| Q4 25 | — | 308.1% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | 77.0% | ||
| Q1 25 | — | 69.1% | ||
| Q4 24 | — | 185.3% | ||
| Q3 24 | — | 60.4% | ||
| Q2 24 | — | 49.7% | ||
| Q1 24 | — | — |
资本支出强度ASRTSWKH
| Q4 25 | — | 5.9% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.0% |
现金转化率ASRTSWKH
| Q4 25 | — | — | ||
| Q3 25 | -0.42× | 0.10× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 3.93× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | 1.47× | ||
| Q1 24 | — | 9.47× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
SWKH
| Finance Receivables Segment | $8.4M | 96% |
| Other | $329.0K | 4% |
